Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver-Reference-Cited by-同舟云学术

Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the Liver

Published:2006-12 Issue:12 Volume:17 Page:1214-1224
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Kemeny Nancy¹,Brown Karen²,Covey Anne²,Kim Teresa³,Bhargava Amit³,Brody Lynn²,Guilfoyle Brenda³,Haag Natasha P.⁴,Karrasch Matthias⁵,Glasschroeder Birgit⁵,Knoll Anette⁵,Getrajdman George²,Kowal K. Jon⁶,Jarnagin William R.³,Fong Yuman³

Affiliation:

1. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

2. Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

3. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

4. George Washington University Medical Center, Washington, DC 20037.

5. MediGene, 82152 Martinsried, Germany.

6. MediGene, San Diego, CA 92131.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2006.17.1214

Reference39 articles.

1. Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

2. Cytokine Toxicity and Induction of NO Synthase Activity in Cultured Mouse Hepatocytes

3. A Novel Approach to Cancer Therapy Using an Oncolytic Herpes Virus to Package Amplicons Containing Cytokine Genes

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical safety assessment of an oncolytic herpes simplex virus type 2 expressed PD-L1/CD3 bispecific antibody;International Immunopharmacology;2023-11

2. Development and application of oncolytic viruses as the nemesis of tumor cells;Frontiers in Microbiology;2023-06-12

3. HSV: The scout and assault for digestive system tumors;Frontiers in Molecular Biosciences;2023-02-28

4. The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles;International Journal of Molecular Sciences;2023-02-12

5. Extracellular Vesicles: a Trojan Horse Delivery Method for Systemic Administration of Oncolytic Viruses;Regenerative Engineering and Translational Medicine;2023-02-07